Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Diabetes and Periodontal Therapy Trial (DPTT)

17. januar 2014 opdateret af: Stony Brook University

A Multicenter Randomized Single-Masked Clinical Trial Testing the Effect of Non-surgical Periodontal Therapy on Glycosylated Hemoglobin (HbA1c) Levels in Subjects With Type 2 Diabetes and Chronic Periodontitis

The primary aim of the study is to determine if non-surgical periodontal therapy (scaling and root planing and supportive periodontal therapy) is efficacious compared to delayed therapy in reducing elevated glycosylated hemoglobin (HbA1c) at 6 months post-randomization in subjects with type 2 diabetes and untreated, moderate to advanced chronic periodontitis.

The secondary aims of the study are to:

  1. evaluate whether 6 month (or shorter-term (3 month)) changes in clinical measures of chronic periodontitis (gingival index, bleeding on probing, probing depth, clinical attachment level) are related to changes in HbA1c and fasting glucose or insulin resistance as measured by the Homeostasis Model Assessment 2 (HOMA2).
  2. assess the 3 month and 6 month efficacy of periodontal therapy on all of the above study outcomes. If a treatment response is observed for any of the study outcomes at 3 months, then the trial can evaluate whether this response is sustained at 6 months.

Studieoversigt

Detaljeret beskrivelse

This study is a multicenter, randomized, controlled, single-masked, Phase III trial to determine if non-surgical periodontal therapy (scaling and root planing) is efficacious in reducing elevated glycosylated hemoglobin (HbA1c) at 6 months post-randomization in subjects with type 2 diabetes and untreated, moderate to advanced chronic periodontitis. Six hundred adults with a diagnosis of type 2 diabetes and chronic periodontitis will be randomized at three Clinical Sites; University of Alabama at Birmingham; the University of Minnesota, Minneapolis; and the University of Texas Health Science Center, San Antonio. The Core Laboratory will be located at the University of Minnesota and the Study Chair's Office and Coordinating Center will be located at Stony Brook University, Stony Brook, New York.

Eligible participants will be randomly assigned to receive either initial non-surgical periodontal therapy with chlorhexidine rinse (treatment subjects) or delayed non-surgical periodontal therapy (control subjects). Control subjects will be offered delayed periodontal therapy (scaling and root planing) following the 6 month visit. Participants meeting all other eligibility criteria and needing essential dental care, i.e., for broken, grossly carious or abscessed teeth, may enroll only following completion of necessary dental treatment. Participants in both study arms will receive oral hygiene instruction and healthy lifestyle information (e.g. diet, exercise) at baseline and at the 3 and 6 month visits.

Periodontal data will be recorded by trained and calibrated examiners at baseline and 3 and 6 months following randomization. Fasting blood will collected at baseline and at 3 and 6 months to measure intermediate links in the putative causal chain between periodontitis and glycemic control. The periodontal health of all subjects will be monitored, and any subject who experiences progressive periodontitis during the study will be provided with non-surgical rescue therapy.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

514

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35294
        • Clinical Site: University of Alabama at Birmingham
    • Minnesota
      • Minneapolis, Minnesota, Forenede Stater, 55455
        • Clinical Site: University of Minnesota
      • Minneapolis, Minnesota, Forenede Stater, 55455
        • Core Laboratory: University of Minnesota
    • New York
      • Stony Brook, New York, Forenede Stater, 11794-8036
        • Coordinating Center: Stony Brook University-
      • Stony Brook, New York, Forenede Stater, 11794
        • Administrative Center/Study Chair's Office: Stony Brook University
      • Stony Brook, New York, Forenede Stater, 11794
        • Clinical Site: Stony Brook University
    • Texas
      • Houston, Texas, Forenede Stater, 77030
        • University of Texas, Health Sciences Center at Houston
      • San Antonio, Texas, Forenede Stater, 78229
        • Clinical Site: University of Texas Health Science Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

35 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • At least 35 years of age
  • Screening HbA1c value ≥ 7% and <9%
  • Physician diagnosed type 2 diabetes of more than three months duration
  • Currently under the care of a physician for diabetes management
  • No change in diabetes-related medications during the three months prior to enrollment. Change is defined as any of the following: change in dose of any 1 hyperglycemic drug by more than two-fold, change in dose of insulin of more than 10%, addition or subtraction of an oral hyperglycemic agent or insulin.
  • Consent to contact treating physician and obtain physician agreement to refrain from changing diabetes- related medications during DPTT participation unless overt symptoms develop (e.g. polydipsia, polyuria), HbA1c is 9.5% or higher
  • Moderate to severe chronic periodontitis, defined as loss of clinical attachment and probing depth of ≥5 mm at two sites in the mouth in 2 or more quadrants
  • No definitive periodontal treatment during the six months prior to enrollment
  • Likely to have at least 16 natural teeth for the entire length of study
  • Informed consent obtained and signed
  • Ability and willingness to cooperate with the study protocol and attend all study visits over the next 9 months
  • Willingness to avoid pregnancy during study participation

Exclusion Criteria:

  • Self-reported serious concurrent disease that at the discretion of the referring physician limits life expectancy to less than 1 year.
  • Emergency room visit or physician visit within the last 30 days because of hyperglycemia or diabetes complications.
  • Chronic or continuous use (daily for more than 7 consecutive days) of nonsteroidal anti-inflammatory drugs within the preceding 2 months, other than low dose aspirin (e.g. 75-325 mg/day).
  • Receiving chronic treatment with systemic corticosteroids, cyclosporine or other systemic immunosuppressive drugs
  • Chronic treatment with systemic antibiotics (antibiotics for > 7 consecutive days within 30 days of baseline visit).
  • Currently receiving dialysis.
  • At increased risk of bleeding complications from dental treatment, based on medical history.
  • Requires Essential Dental Care (e.g., treatment for grossly decayed teeth, broken teeth, dental abscesses, peri-apical infections, other dental infections).
  • Heavy alcohol consumption (on average > 2 drinks/day for women and > 3 drinks/day for men).
  • Currently pregnant or considering becoming pregnant within the 6 month follow-up period
  • Any other criteria that in the opinion of the investigator would preclude study completion or problems with compliance

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Non-surgical periodontal therapy
Non-surgical periodontal therapy consisted of scaling and root planing plus chlorhexidine oral rinse at baseline and supportive periodontal therapy at 3 and 6 months
Non-surgical periodontal therapy (scaling and root planing)and supportive periodontal therapy with chlorhexidine rinse
Andet: Delayed non-surgical periodontal therapy
No periodontal treatment for 6 months
Delayed non-surgical periodontal therapy (scaling and root planing) after the 6 month visit

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Change in Glycosylated Hemoglobin (HbA1c)
Tidsramme: 6 months after randomization
6 months after randomization

Sekundære resultatmål

Resultatmål
Tidsramme
Change in glycosylated hemoglobin (HbA1c)
Tidsramme: 3 months after randomization
3 months after randomization
Change in Fasting Plasma Glucose and Homeostasis Model Assessment 2 (HOMA2)
Tidsramme: 3 and 6 months after randomization
3 and 6 months after randomization
Change in clinical measures of chronic periodontitis (gingival index, bleeding on probing, probing depth, clinical attachment level)
Tidsramme: 3 and 6 months after randomization
3 and 6 months after randomization
Need for Periodontal Rescue Therapy
Tidsramme: When required
When required
Change in diabetes medications
Tidsramme: 3 and 6 months after randomization
3 and 6 months after randomization
Need for Diabetes Rescue Therapy
Tidsramme: When required
When required

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studiestol: Steven Engebretson, DMD, MS, MS, Stony Brook University
  • Studieleder: Leslie Hyman, PhD, Stony Brook University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. oktober 2009

Primær færdiggørelse (Faktiske)

1. oktober 2012

Studieafslutning (Faktiske)

1. december 2012

Datoer for studieregistrering

Først indsendt

16. oktober 2009

Først indsendt, der opfyldte QC-kriterier

16. oktober 2009

Først opslået (Skøn)

19. oktober 2009

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

20. januar 2014

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. januar 2014

Sidst verificeret

1. januar 2014

Mere information

Begreber relateret til denne undersøgelse

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Type 2 diabetes

Kliniske forsøg med Non-surgical periodontal therapy

3
Abonner